Clinical Trial Update: Nebulizer Delivery of Intranasal Scopolamine [Phase 1]

View source ↗

Summary

This update reports the completion of a Phase 1 trial evaluating nebulized intranasal scopolamine for motion sickness.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Motion Sickness

Drugs mentioned

• SCOPOLAMINE (SCOPOLAMINE)

Snippet

Sponsor: Dartmouth-Hitchcock Medical Center | Conditions: Scopolamine, Motion Sickness | Phase 1 | Status: COMPLETED